Bard Pharmaceuticals is a finished-dose manufacturer based in United Kingdom. It appears in 30 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with NPRA (MY), EDE (AE) and Health Canada. Its GMP standing is certified by MHRA (UK) and ANVISA (Brazil).
| Site | FDA FEI |
|---|---|
| CAMBRIDGE, United Arab Emirates | Not on file |
| CAMBRIDGE, United Kingdom | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| NPRA (MY) | 9 | None |
| EDE (AE) | 8 | None |
| Health Canada | 5 | None |
| ARCSA (EC) | 4 | None |
| MINSA (CR) | 3 | None |
| DAV (Vietnam) | 1 | None |
| MHRA (UK) | None | 4 |
| ANVISA (Brazil) | None | 2 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Ask Fred what the record holds on Bard Pharmaceuticals, including filings and inspection history.
Chat with Fred, your AI analystRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.